Aruba Science Wire
SEE OTHER BRANDS

Your best source on science and technology news from Aruba

Symbotic Reports Third Quarter Fiscal Year 2025 Results

WILMINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its third quarter of fiscal year 2025, which ended on June 28, 2025. Symbotic reported revenue of $592 million, a net loss of $32 million and adjusted EBITDA1 of $45 million for the third quarter of fiscal year 2025.

In comparison, Symbotic posted revenue of $470 million, a net loss of $27 million and adjusted EBITDA1 of $3 million in the third quarter of fiscal year 2024.

Cash and cash equivalents decreased by $177 million from the prior quarter, totaling $778 million at the end of the third quarter of fiscal year 2025.

“We continue to deliver strong results and drive operational progress,” said Rick Cohen, Symbotic Chairman and Chief Executive Officer. “We are building on this momentum with game-changing innovations that are unlocking new opportunities across the supply chain as we have unveiled with our next generation storage structure.”

“Revenue grew 26% and gross margins improved once again year-over-year,” said Carol Hibbard, Symbotic Chief Financial Officer. “Looking ahead, with the launch of a proprietary new storage structure, we expect a temporary short-term impact on revenue based on schedules shifting to accommodate. Importantly, the new structure does not affect our backlog and supports our long-term value creation.”

OUTLOOK

For the fourth quarter of fiscal 2025, Symbotic expects revenue of $590 million to $610 million, and adjusted EBITDA2 of $45 million to $49 million.

WEBCAST INFORMATION

Symbotic will host a webcast today at 5:00 pm ET to discuss its third quarter of fiscal year 2025 results. The webcast link is: https://edge.media-server.com/mmc/go/Symbotic-Q3-2025.

_______________
1 Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is a non-GAAP financial measure as defined below under “Use of Non-GAAP Financial Information.” See the tables below for reconciliations to net loss, the most comparable GAAP measure.

2 Symbotic is not providing guidance for net loss, which is the most comparable GAAP financial measure to adjusted EBITDA, because information reconciling forward-looking adjusted EBITDA to net loss is unavailable to it without unreasonable effort. Symbotic is not able to provide reconciliations of adjusted EBITDA to GAAP financial measures because certain items required for such reconciliations are outside of Symbotic’s control and/or cannot be reasonably predicted, such as restructuring charges and the provision for stock-based compensation.

ABOUT SYMBOTIC

Symbotic is an automation technology leader reimagining the supply chain with its end-to-end, A.I.-powered robotic and software platform. Symbotic reinvents the warehouse as a strategic asset for the world’s largest retail, wholesale, and food & beverage companies. Applying next-generation

technology, high-density storage and machine learning to solve today's complex distribution challenges, Symbotic enables companies to move goods with unmatched speed, agility, accuracy and efficiency. As the backbone of commerce, Symbotic transforms the flow of goods and the economics of the supply chain for its customers. For more information, visit www.symbotic.com.

USE OF NON-GAAP FINANCIAL INFORMATION

Symbotic reports its financial results in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”). This press release contains financial measures that are not recognized under U.S. GAAP (“non-GAAP financial measures”), including adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow. These non-GAAP financial measures have limitations as an analytical tool as they do not have a standardized meaning prescribed by U.S. GAAP. The non-GAAP financial measures Symbotic uses may not be the same non-GAAP financial measures, and may not be calculated in the same manner, as that of other companies and, therefore, are unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP financial measures are provided as a supplement to corresponding U.S. GAAP measures to provide additional information regarding the results of operations from management’s perspective. Accordingly, non-GAAP financial measures should not be considered a substitute for, in isolation from, or superior to, the financial information prepared and presented in accordance with U.S. GAAP. All non-GAAP financial measures presented in this press release are reconciled to their closest reported U.S. GAAP financial measures. Symbotic recommends that investors review the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures provided in the financial statement tables included below in this press release, and not rely on any single financial measure to evaluate its business.

Symbotic defines adjusted EBITDA, a non-GAAP financial measure, as GAAP net loss excluding the following items: interest income; income taxes; depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; equity method investment; internal control remediation; business transformation costs; fair value adjustments on strategic investments; restructuring charges; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines adjusted gross profit, a non-GAAP financial measure, as GAAP gross profit excluding the following items: depreciation, stock-based compensation, and restructuring charges. Symbotic defines adjusted gross profit margin, a non-GAAP financial measure, as adjusted gross profit divided by total revenue. Symbotic defines adjusted research and development expenses, a non-GAAP financial measure, as GAAP research and development expenses excluding the following items: depreciation and amortization of tangible and intangible assets and stock-based compensation. Symbotic defines adjusted selling, general, and administrative expenses, a non-GAAP financial measure, as GAAP selling, general, and administrative expenses excluding the following items: depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; internal control remediation; business transformation costs; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines free cash flow, a non-GAAP financial measure, as net cash provided by or used in operating activities less purchases of property and equipment and capitalization of internal use software development costs. In addition to Symbotic’s financial results determined in accordance with U.S. GAAP, Symbotic believes that adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow non-GAAP financial measures, are useful in evaluating the performance of Symbotic’s business because they highlight trends in its core business.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, Symbotic’s expectations or predictions of future financial or business performance or conditions. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning our possible or assumed future actions, business strategies, events, backlog or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or similar expressions.

Forward-looking statements include, but are not limited to, statements about the ability of or expectations regarding, Symbotic to:

  • meet the technical requirements of existing or future supply agreements with its customers, including with respect to existing backlog;
  • expand its target customer base and maintain its existing customer base;
  • realize the benefits expected from the acquisition of Walmart’s Advanced Systems and Robotics business, the GreenBox joint venture, the Commercial Agreement with GreenBox, Symbotic’s acquisitions of developed technology intangible assets, and the commercial agreement with Walmart de México y Centroamérica;
  • realize its outlook, including its system gross margin;
  • anticipate industry trends;
  • maintain and enhance its system;
  • maintain the listing of the Symbotic Class A Common Stock on Nasdaq;
  • execute its growth strategy;
  • develop, design and sell systems that are differentiated from those of competitors;
  • execute its research and development strategy;
  • acquire, maintain, protect and enforce intellectual property;
  • attract, train and retain effective officers, key employees or directors;
  • comply with laws and regulations applicable to its business;
  • stay abreast of modified or new laws and regulations applying to its business;
  • successfully defend litigation;
  • issue equity securities in connection with future transactions;
  • meet future liquidity requirements and, if applicable, comply with restrictive covenants related to long-term indebtedness;
  • timely and effectively remediate any material weaknesses in its internal control over financial reporting;
  • anticipate rapid technological changes; and
  • effectively respond to general economic and business conditions.

Forward-looking statements also include, but are not limited to, statements with respect to:

  • the future performance of Symbotic’s business and operations;
  • expectations regarding revenues, expenses, adjusted EBITDA and anticipated cash needs;
  • expectations regarding cash flow, liquidity and sources of funding;
  • the next generation storage structure;
  • expectations regarding capital expenditures;
  • the anticipated benefits of Symbotic’s leadership structure;
  • the effects of pending and future legislation, regulation and trade practices, including tariffs;
  • business disruption;
  • disruption to the business due to Symbotic’s dependency on certain customers;
  • increasing competition in the warehouse automation industry;
  • any delays in the design, production or launch of Symbotic’s systems and products;
  • the failure to meet customers’ requirements under existing or future contracts or customer’s expectations as to price or pricing structure;   
  • any defects in new products or enhancements to existing products;  
  • the fluctuation of operating results from period to period due to a number of factors, including the pace of customer adoption of Symbotic’s new products and services and any changes in its product mix that shift too far into lower gross margin products; and
  • any consequences associated with joint ventures and legislative and regulatory actions and reforms.

Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. Certain of these risks are identified and discussed in Symbotic’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024, filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 4, 2024. These risk factors will be important to consider in determining future results and should be reviewed in their entirety. These forward-looking statements are expressed in good faith, and Symbotic believes there is a reasonable basis for them. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management’s current expectations and plans relating to the future, and the reader is cautioned not to place undue reliance on these forward-looking statements because of their inherent uncertainty and to appreciate the limited purposes for which they are being used by management. While we believe that the assumptions and expectations reflected in the forward-looking statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-looking statements speak only as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. Symbotic is not under any obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports that Symbotic has filed or will file from time to time with the SEC.

In addition to factors previously disclosed in Symbotic’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024 filed with the SEC on December 4, 2024 and those identified elsewhere in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: failure to realize the benefits expected from the acquisition of Walmart’s Advanced Systems and Robotics business and risks related to the acquisition.

Any financial projections in this press release or discussed in the webcast are forward-looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyond Symbotic’s control. While all projections are necessarily speculative, Symbotic believes that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection extends from the date of preparation. The assumptions and estimates underlying the projected results are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections. The inclusion of projections in this communication should not be regarded as an indication that Symbotic, or its representatives, considered or considers the projections to be a reliable prediction of future events.

Annualized, projected and estimated numbers are not forecasts and may not reflect actual results.

This communication is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Symbotic and is not intended to form the basis of an investment decision in Symbotic. The forward-looking statements contained in this press release and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements.

INVESTOR RELATIONS CONTACT

Charlie Anderson
Vice President, Investor Relations & Corporate Development
ir@symbotic.com

MEDIA INQUIRIES

mediainquiry@symbotic.com

Symbotic Inc. and Subsidiaries
Consolidated Statements of Operations

  Three Months Ended   Nine Months Ended
 (in thousands, except share and per share information) June 28, 2025   March 29, 2025   June 29, 2024   June 28, 2025   June 29, 2024
Revenue:                  
Systems $ 559,108     $ 513,372     $ 450,595     $ 1,536,539     $ 1,168,993  
Software maintenance and support   8,121       6,685       3,545       20,331       8,280  
Operation services   24,892       29,594       16,198       71,595       46,340  
Total revenue   592,121       549,651       470,338       1,628,465       1,223,613  
Cost of revenue:                  
Systems   457,911       414,560       398,761       1,254,289       1,024,832  
Software maintenance and support   1,756       2,095       2,539       5,735       6,201  
Operation services   24,832       25,168       14,065       72,952       43,331  
Total cost of revenue   484,499       441,823       415,365       1,332,976       1,074,364  
Gross profit   107,622       107,828       54,973       295,489       149,249  
Operating expenses:                  
Research and development expenses   52,147       61,540       44,722       157,279       133,327  
Selling, general, and administrative expenses   75,670       78,347       47,871       215,092       143,535  
Restructuring charges   16,361                   16,361        
Total operating expenses   144,178       139,887       92,593       388,732       276,862  
Operating loss   (36,556 )     (32,059 )     (37,620 )     (93,243 )     (127,613 )
Other income, net   8,451       11,714       11,615       27,987       27,626  
Loss before income tax and equity method investment   (28,105 )     (20,345 )     (26,005 )     (65,256 )     (99,987 )
Income tax expense (benefit)   (44 )     1,397       (182 )     1,204       (102 )
Loss from equity method investment   (3,776 )     (2,490 )     (537 )     (7,831 )     (537 )
Net loss   (31,925 )     (21,438 )     (26,724 )     (71,883 )     (100,626 )
Net loss attributable to noncontrolling interests   (26,012 )     (17,513 )     (22,043 )     (58,569 )     (84,300 )
Net loss attributable to common stockholders $ (5,913 )   $ (3,925 )   $ (4,681 )   $ (13,314 )   $ (16,326 )
                   
Loss per share of Class A Common Stock:                  
Basic and Diluted $ (0.05 )   $ (0.04 )   $ (0.05 )     (0.12 )   $ (0.18 )
Weighted-average shares of Class A Common Stock outstanding:                  
Basic and Diluted   109,201,745       107,726,978       102,414,284       107,664,864       92,891,276  
 
Symbotic Inc. and Subsidiaries
Reconciliation of Non-GAAP Financial Measures
 

The following table reconciles GAAP net loss to Adjusted EBITDA:

  Three Months Ended   Nine Months Ended
(in thousands) June 28, 2025   March 29, 2025   June 29, 2024   June 28, 2025   June 29, 2024
Net loss $ (31,925 )   $ (21,438 )   $ (26,724 )   $ (71,883 )   $ (100,626 )
Interest income   (8,373 )     (7,229 )     (11,610 )     (23,371 )     (27,554 )
Income tax expense (benefit)   44       (1,397 )     182       (1,204 )     102  
Depreciation and amortization   12,940       11,169       10,032       30,969       15,065  
Stock-based compensation   50,279       47,962       30,320       126,982       94,508  
Business Combination transaction expenses   422       3,298             7,522        
Equity method investment   3,776       2,490       537       7,831       537  
Internal control remediation   1,795       2,175             7,046        
Business transformation costs   75       2,400             2,475        
Fair value adjustments on strategic investments         (4,481 )           (4,481 )      
Restructuring charges   16,361       (231 )           16,130       34,206  
Joint venture formation fees                           1,089  
Equity financing transaction costs                           1,985  
Adjusted EBITDA $ 45,394     $ 34,718     $ 2,737     $ 98,016     $ 19,312  
                                       

The following table reconciles GAAP gross profit to Adjusted gross profit:

  Three Months Ended   Nine Months Ended
(in thousands) June 28, 2025   March 29, 2025   June 29, 2024   June 28, 2025   June 29, 2024
Gross profit $ 107,622     $ 107,828     $ 54,973     $ 295,489     $ 149,249  
Depreciation   3,538       2,949       5,359       8,957       5,540  
Stock-based compensation   16,034       11,264       3,807       31,006       12,394  
Restructuring charges         (231 )           (231 )     34,206  
Adjusted gross profit $ 127,194     $ 121,810     $ 64,139     $ 335,221     $ 201,389  


Gross profit margin   18.2 %     19.6 %     11.7 %     18.1 %     12.2 %
Adjusted gross profit margin   21.5 %     22.2 %     13.6 %     20.6 %     16.5 %
                                       

The following table reconciles GAAP research and development expenses to Adjusted research and development expenses:

  Three Months Ended   Nine Months Ended
(in thousands) June 28, 2025   March 29, 2025   June 29, 2024   June 28, 2025   June 29, 2024
Research and development expenses $ 52,147     $ 61,540     $ 44,722     $ 157,279     $ 133,327  
Depreciation and amortization   (7,133 )     (5,611 )     (1,250 )     (15,044 )     (3,236 )
Stock-based compensation   (12,860 )     (15,608 )     (13,279 )     (40,719 )     (41,728 )
Adjusted research and development expenses $ 32,154     $ 40,321     $ 30,193     $ 101,516     $ 88,363  
                                       

The following table reconciles GAAP selling, general, and administrative expenses to Adjusted selling, general, and administrative expenses:

  Three Months Ended   Nine Months Ended
(in thousands) June 28, 2025   March 29, 2025   June 29, 2024   June 28, 2025   June 29, 2024
Selling, general, and administrative expenses $ 75,670     $ 78,347     $ 47,871     $ 215,092     $ 143,535  
Depreciation and amortization   (2,270 )     (2,609 )     (3,423 )     (6,969 )     (6,294 )
Stock-based compensation   (21,385 )     (21,091 )     (13,235 )     (55,257 )     (40,385 )
Business combination transaction expenses   (422 )     (3,298 )           (7,522 )      
Internal control remediation   (1,795 )     (2,175 )           (7,046 )      
Business transformation costs   (75 )     (2,400 )           (2,475 )      
Joint venture formation fees                           (1,089 )
Equity financing transaction costs                           (1,985 )
Adjusted selling, general, and administrative expenses $ 49,723     $ 46,774     $ 31,213     $ 135,823     $ 93,782  
                                       

The following table reconciles GAAP net cash provided by (used in) operating activities to free cash flow:

  Three Months Ended   Nine Months Ended
(in thousands) June 28, 2025   March 29, 2025   June 29, 2024   June 28, 2025   June 29, 2024
Net cash provided by (used in) operating activities $ (138,343 )   $ 269,575     $ 50,384     $ 336,259     $ 41,306  
Purchases of property and equipment and capitalization of internal use software development costs   (14,867 )     (20,560 )     (17,143 )     (42,784 )     (23,007 )
Free cash flow $ (153,210 )   $ 249,015     $ 33,241     $ 293,475     $ 18,299  
 
Symbotic Inc. and Subsidiaries
Supplemental Common Share Information
 

Total Common Shares issued and outstanding:

  June 28, 2025
  September 28, 2024
Class A Common Shares issued and outstanding   110,252,933       104,689,377  
Class V-1 Common Shares issued and outstanding   76,015,171       76,965,386  
Class V-3 Common Shares issued and outstanding   403,559,196       404,309,196  
    589,827,300       585,963,959  
               


Symbotic Inc. and Subsidiaries
Consolidated Balance Sheets
 
(in thousands, except share data) June 28, 2025   September 28, 2024
ASSETS
Current assets:      
Cash and cash equivalents $ 777,576     $ 727,310  
Accounts receivable   136,237       201,548  
Unbilled accounts receivable   236,433       218,233  
Inventories   138,901       106,136  
Deferred expenses   35,545       1,058  
Prepaid expenses and other current assets   101,516       101,252  
Total current assets   1,426,208       1,355,537  
Property and equipment, net   73,013       97,109  
Intangible assets, net   82,921       3,664  
Goodwill   60,534        
Equity method investment   105,551       81,289  
Other assets   79,184       40,953  
Total assets $ 1,827,411     $ 1,578,552  
LIABILITIES AND EQUITY
Current liabilities:      
Accounts payable $ 215,624     $ 175,188  
Accrued expenses and other current liabilities   183,690       165,644  
Deferred revenue   918,097       676,314  
Total current liabilities   1,317,411       1,017,146  
Deferred revenue   5,044       129,233  
Other liabilities   61,544       42,043  
Total liabilities   1,383,999       1,188,422  
Commitments and contingencies          
Equity:      
Class A Common Stock, 3,000,000,000 shares authorized, 110,252,933 and 104,689,377 shares issued and outstanding at June 28, 2025 and September 28, 2024, respectively   13       13  
Class V-1 Common Stock, 1,000,000,000 shares authorized, 76,015,171 and 76,965,386 shares issued and outstanding at June 28, 2025 and September 28, 2024, respectively   7       7  
Class V-3 Common Stock, 450,000,000 shares authorized, 403,559,196 and 404,309,196 shares issued and outstanding at June 28, 2025 and September 28, 2024, respectively   40       40  
Additional paid-in capital   1,550,610       1,523,692  
Accumulated deficit   (1,337,239 )     (1,323,925 )
Accumulated other comprehensive loss   (2,678 )     (2,594 )
Total stockholders' equity   210,753       197,233  
Noncontrolling interest   232,659       192,897  
Total equity   443,412       390,130  
Total liabilities and equity $ 1,827,411     $ 1,578,552  
               


Symbotic Inc. and Subsidiaries
Consolidated Statements of Cash Flows
 
  Three Months Ended   Nine Months Ended
(in thousands) June 28, 2025   March 29, 2025   June 29, 2024   June 28, 2025   June 29, 2024
Cash flows from operating activities:                  
Net loss $ (31,925 )   $ (21,438 )   $ (26,724 )   $ (71,883 )   $ (100,626 )
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:                  
Depreciation and amortization   14,202       12,279       10,696       34,126       17,048  
Loss from equity method investment   3,776       4,055       537       7,831       537  
Foreign currency (gains) losses, net   (61 )     20             (73 )     (8 )
Gain on investments               (1,339 )           (10,084 )
Loss on disposal of assets                     201        
Provision for excess and obsolete inventory   3,921       292       (171 )     4,901       34,105  
Stock-based compensation   49,440       43,355       29,331       119,568       86,858  
Gain from strategic investment fair value adjustment         (4,481 )           (4,481 )      
Changes in operating assets and liabilities:                  
Accounts receivable   1,389       (3,195 )     27,166       65,570       (31,295 )
Inventories   3,470       (23,232 )     (12,179 )     (30,187 )     (30,099 )
Prepaid expenses and other current assets   (37,107 )     89,491       45,269       62,701       2,839  
Deferred expenses   27,503       (1,757 )     (5,580 )     23,582       (10,626 )
Other assets   (9,449 )     (6,400 )     514       (16,928 )     (4,952 )
Accounts payable   (4,407 )     13,806       (5,444 )     40,544       17,871  
Accrued expenses and other current liabilities   12,532       (65,685 )     50,477       (7,613 )     48,593  
Deferred revenue   (171,331 )     230,283       (60,635 )     117,288       12,009  
Other liabilities   (296 )     2,182       (1,534 )     (8,888 )     9,136  
Net cash provided by (used in) operating activities   (138,343 )     269,575       50,384       336,259       41,306  
Cash flows from investing activities:                  
Purchases of property and equipment and capitalization of internal use software development costs   (14,867 )     (20,560 )     (17,143 )     (42,784 )     (23,007 )
Proceeds from maturities of marketable securities               50,000             340,000  
Purchases of marketable securities                           (48,660 )
Acquisitions of strategic investments   (24,233 )           (66,489 )     (42,225 )     (66,489 )
Cash paid for business acquisitions         (200,000 )           (200,000 )      
Net cash provided by (used in) investing activities   (39,100 )     (220,560 )     (33,632 )     (285,009 )     201,844  
Cash flows from financing activities:                  
Payment for taxes related to net share settlement of stock-based compensation awards                     (3,012 )     (3,181 )
Net proceeds from issuance of common stock under employee stock purchase plan         3,233             3,233       3,435  
Distributions to or on behalf of Symbotic Holdings LLC partners   57       (382 )     (47,654 )     (1,175 )     (47,654 )
Proceeds from issuance of Class A Common Stock                           257,985  
Proceeds from exercise of warrants               2             158,704  
Net cash provided by (used in) financing activities   57       2,851       (47,652 )     (954 )     369,289  
Effect of exchange rate changes on cash, cash equivalents, and restricted cash   24       50       (10 )     (10 )     (25 )
Net increase (decrease) in cash, cash equivalents, and restricted cash   (177,362 )     51,916       (30,910 )     50,286       612,414  
Cash, cash equivalents, and restricted cash - beginning of period   958,002       906,086       904,242       730,354       260,918  
Cash, cash equivalents, and restricted cash - end of period $ 780,640     $ 958,002     $ 873,332     $ 780,640     $ 873,332  
                   
                   
  Three Months Ended   Nine Months Ended
(in thousands) June 28, 2025   March 29, 2025   June 29, 2024   June 28, 2025   June 29, 2024
Reconciliation of cash, cash equivalents, and restricted cash:                  
Cash and cash equivalents $ 777,576     $ 954,944     $ 870,469     $ 777,576     $ 870,469  
Restricted cash   3,064       3,058       2,863       3,064       2,863  
Cash, cash equivalents, and restricted cash $ 780,640     $ 958,002     $ 873,332     $ 780,640     $ 873,332  
                                       

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions